产品描述信息
NR-10046?? Genomic RNA from Influenza A Virus, A/Brisbane/10/2007 (HA, NA) x A/Puerto Rico/8/1934 (H3N2), Reassortant IVR-147(Nucleic Acids)|Influenza A virus|Genomic RNA from Influenza A Virus, A/Brisbane/10/2007 (HA, NA) x A/Puerto Rico/8/1934 (H3N2), Reassortant IVR-147|-60°C or colder|A KlimovAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Genomic RNA from Influenza A Virus, A/Brisbane/10/2007 (HA, NA) x A/Puerto Rico/8/1934 (H3N2), Reassortant IVR-147, NR-10046."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.Genomic RNA was isolated from a preparation of pooled allantoic fluid from specific-pathogen free embryonated chicken eggs infected with reassortant influenza A virus, A/Brisbane/10/2007 (HA, NA) x A/Puerto Rico/8/1934 (H3N2) (IVR-147).Influenza A/Brisbane/10/2007 (H3N2) was originally isolated in Brisbane, Australia on February 6, 2007 from a human nasal swab. Influenza A/Brisbane/10/2007 (H3N2)-like viruses have been used as the influenza A (H3N2) component of trivalent vaccines worldwide since 2008.NR-10046 has been qualified for PCR applications by amplification of an approximately 1030 nucleotide sequence. Each vial contains 100 ?L of viral genomic RNA in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.0) containing sodium azide. The viral genomic RNA is in a background of cellular nucleic acid and carrier RNA.